93 related articles for article (PubMed ID: 20667316)
1. Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care?
Moffatt-Bruce SD; Ross P; Leon ME; He G; Finkelstein SD; Vaida AM; Iwenofu OH; Frankel WL; Hitchcock CL
Ann Thorac Surg; 2010 Aug; 90(2):388-96. PubMed ID: 20667316
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
3. Invited commentary.
Danner BC
Ann Thorac Surg; 2010 Aug; 90(2):397. PubMed ID: 20667317
[No Abstract] [Full Text] [Related]
4. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
[TBL] [Abstract][Full Text] [Related]
7. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
[TBL] [Abstract][Full Text] [Related]
8. A rational approach to pulmonary screening in newly diagnosed head and neck cancer.
Loh KS; Brown DH; Baker JT; Gilbert RW; Gullane PJ; Irish JC
Head Neck; 2005 Nov; 27(11):990-4. PubMed ID: 16136584
[TBL] [Abstract][Full Text] [Related]
9. Simultaneously presenting head and neck and lung cancer: a diagnostic and treatment dilemma.
Kuriakose MA; Loree TR; Rubenfeld A; Anderson TM; Datta RV; Hill H; Rigual NR; Orner J; Singh A; Hicks WL
Laryngoscope; 2002 Jan; 112(1):120-3. PubMed ID: 11802049
[TBL] [Abstract][Full Text] [Related]
10. [Two operated cases of synchronous double cancer of the lung and digestive tract in patients over 80 years old and genetical diagnosis].
Nosaka S; Nakayama K; Nio Y; Yamauchi M; Gu K; Sasaki T; Saito Y; Sato Y; Tamura K
Kyobu Geka; 1996 Feb; 49(2):111-5. PubMed ID: 8691677
[TBL] [Abstract][Full Text] [Related]
11. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
[TBL] [Abstract][Full Text] [Related]
12. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
14. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
[TBL] [Abstract][Full Text] [Related]
15. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
[TBL] [Abstract][Full Text] [Related]
17. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
